On the Use of DSC-MRI for Measuring Vascular Permeability

American Journal of Neuroradiology

Volumn 37, Issue 1, 2016, Pages 80-87

  Skinner, J T ^a,b   Moots, P L ^d   Ayers, G D ^b   Quarles, C C ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOPENAMIDE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; TISSUE BLOOD FLOW; AGED; ARTIFACT; BIOPHYSICS; BRAIN TUMOR; CAPILLARY PERMEABILITY; CONTRAST MEDIUM EXTRAVASATION; DIFFUSION WEIGHTED IMAGING; IMAGE PROCESSING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; BIOPHYSICAL PHENOMENA; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; GADOLINIUM DTPA; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED;

EID: 84955505497     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4478     Document Type: Article

References (41)

1. Shubik P. Vascularization of tumors: a review. J Cancer Res Clin Oncol 1982;103:211-26
2. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859-67
3. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601-13
4. Quarles CC, Gochberg DF, Gore JC, et al. A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 2009;54:5749-66
5. Schmainda KM, Prah M, Connelly J, et al. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. Neuro Oncol 2014;16:880-88
6. Paulson E, Prah DE, Schmainda KM. Compensation of confounding T1 and T2 dipolar and residual susceptibility effects in DSC-MRI using dual-echo SPIRAL. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Berlin, Germany. May 19-25, 2007:2811
7. Weisskoff RM, Boxerman JL, Sorensen AG. Simultaneous blood volume and permeability mapping using a single Gd-based contrast agent. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, San Francisco, California. August 6-12, 1994:279
8. Liu HL, Wu YY, Yang WS, et al. Is Weisskoff model valid for the correction of contrast agent extravasation with combined T1 and T2∗ effects in dynamic susceptibility contrast MRI? Med Phys 2011;38:802-09
9. Quarles CC, Ward BD, Schmainda KM. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005;53:1307-16
10. Bjornerud A, Sorensen AG, Mouridsen K, et al. T1- and T2∗-dominant extravasation correction in DSC-MRI: part I - theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011;31:2041-53
11. Emblem KE, Bjornerud A, Mouridsen K, et al. T(1)- and T(2)(∗)-dominant extravasation correction in DSC-MRI: part II - predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011;31:2054-64
12. Vonken EJ, van Osch MJ, Bakker CJ, et al. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109-17
13. Miyati T, Banno T, Mase M, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 1997;7:230-35
14. Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 2001;22:1915-19
15. Vonken EP, van Osch MJ, Bakker CJ, et al. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000;43:820-27
16. Quarles CC, Gore JC, Xu L, et al. Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters. Magn Reson Imaging 2012;30:944-53
17. Skinner JT, Robison RK, Elder CP, et al. Evaluation of a multiple spin- and gradient-echo (SAGE) EPI acquisition with SENSE acceleration: applications for perfusion imaging in and outside the brain. Magn Reson Imaging 2014;32:1171-80
18. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101
19. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32
20. Schmiedeskamp H, Andre JB, Straka M, et al. Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab 2013;33:732-43
21. Zhang N, Zhang L, Qiu B, et al. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging 2012;36:355-63
22. Cha S, Yang L, Johnson G, et al. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2∗-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 2006;27:409-17
23. Ah-See ML, Makris A, Taylor NJ, et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2008;14:6580-89
24. George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628-36
25. Armitage PA, Schwindack C, Bastin ME, et al. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 2007;25:303-10
26. Batchelor TT, Sorensen AG, di Tomaso E, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007;11:83-95
27. Toh CH, Wei KC, Chang CN, et al. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 2013;34:1145-49
28. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711-16
29. Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000;43:845-53
30. Bonekamp D, Deike K, Wiestler B, et al. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: comparison of intraindividually matched T1- and T2 (∗)-based bolus techniques. J Magn Reson Imaging 2015;42:87-96
31. Schmiedeskamp H, Straka M, Newbould RD, et al. Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med 2012;68:30-40
32. Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003;227:593-600
33. Newton AT, Skinner JT, Quarles CC. Automatic AIF estimation in multi-echo DSC-MRI of pediatric patieints: avoiding the noise floor. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine, Salt Lake City, Utah. April 20-26, 2013
34. Liu HL, Pu Y, Liu Y, et al. Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold. Magn Reson Med 1999;42:167-72
35. Kuperman VY, Karczmar GS, Blomley MJ, et al. Differentiating between T1 and T2∗ changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. J Magn Reson Imaging 1996;6:764-68
36. Landis CS, Li X, Telang FW, et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med 2000;44:563-74
37. Skinner JT, Yankeelov TE, Peterson TE, et al. Comparison of dynamic contrast-enhanced MRI and quantitative SPECT in a rat glioma model. Contrast Media Mol Imaging 2012;7:494-500
38. Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853-58
39. Liu Y, Ding W, Bensheng Q. Extravascular extracellular space fraction measurement by DSC-MRI: a theoretical study. In: Proceedings of the Annual Meeting of the International Society for Magnetic Resonance in Medicine and European Society for Magnetic Resonance in Medicine, Milan, Italy. May 10-16, 2014
40. Semmineh NB, Xu J, Boxerman JL, et al. An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structures. PLoS One 2014;9:e84764
41. Semmineh NB, Xu J, Skinner JT, et al. Assessing tumor cytoarchitecture using multiecho DSC-MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE). Magn Reson Med 2015;74:772-84